| Adeolu Adebayo Adeboye, MD | |
|
1 Guthrie Sq, Sayre, PA 18840-1625 | |
| (570) 888-6666 | |
| Not Available |
| Full Name | Adeolu Adebayo Adeboye |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1 Guthrie Sq, Sayre, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225566086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MT212747 (Pennsylvania) | Primary |
| Entity Name | Florida Trauma Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477296952 PECOS PAC ID: 3971985938 Enrollment ID: O20220808001578 |
News Archive
Survival rates of HIV-positive patients could be improved if combination-drug treatment were begun earlier than current clinical guidelines now recommend, according to a new study by researchers from The New York Academy of Medicine and the Johns Hopkins University Bloomberg School of Public Health.
Virginia Premier Health Plan and Envision Pharmaceutical Services, Inc., today announced a multi-year agreement that establishes Envision as the exclusive provider of pharmacy benefit management (PBM) services for Virginia Premier's 150,000 managed Medicaid members starting 7/1/2012. The agreement is based on the pillars of pass-through pricing, transparency and service that will allow Virginia Premier unprecedented plan access and customization while achieving lower net costs.
New findings from a long-running study of nearly 1300 rural children by UNC's Frank Porter Graham Child Development Institute reveal that parenting deteriorates when families face a number of risk factors at once. As a result, children's intellectual, emotional, and social development suffers.
The U.S. Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adeolu Adebayo Adeboye, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-5858 | Adeolu Adebayo Adeboye, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-6666 |
News Archive
Survival rates of HIV-positive patients could be improved if combination-drug treatment were begun earlier than current clinical guidelines now recommend, according to a new study by researchers from The New York Academy of Medicine and the Johns Hopkins University Bloomberg School of Public Health.
Virginia Premier Health Plan and Envision Pharmaceutical Services, Inc., today announced a multi-year agreement that establishes Envision as the exclusive provider of pharmacy benefit management (PBM) services for Virginia Premier's 150,000 managed Medicaid members starting 7/1/2012. The agreement is based on the pillars of pass-through pricing, transparency and service that will allow Virginia Premier unprecedented plan access and customization while achieving lower net costs.
New findings from a long-running study of nearly 1300 rural children by UNC's Frank Porter Graham Child Development Institute reveal that parenting deteriorates when families face a number of risk factors at once. As a result, children's intellectual, emotional, and social development suffers.
The U.S. Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
› Verified 3 days ago
Richard Choe, MD Surgery Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 917-583-6090 | |
Dr. Lawrence Nathan Sampson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 | |
Dr. Charles Robert Argila, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-887-6724 Fax: 570-887-6728 | |
Alice Shih Yuan Shen, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-882-3585 | |
Dr. Anthony R. Gillott, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 Fax: 570-887-2338 | |
Karim W Sadik, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-887-2855 Fax: 570-887-2033 | |
Dr. Richard Anthony Damian, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 Fax: 570-887-2338 |